Optimization of pellets containing solid dispersion prepared by extrusion/spheronization using central composite design and desirability function

Journal of Young Pharmacists

Volumn 4, Issue 3, 2012, Pages 146-156

  Singh, Gurinder ^a   Pai, Roopa S ^a   Kusum Devi, V ^a  

^a AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

Central composite design; desirability function; furosemide; solid dispersion; sustained release pellets

Indexed keywords

EUDRAGIT; FUROSEMIDE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PELLET; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; IN VITRO STUDY; MATHEMATICAL MODEL; PARTICLE SIZE; PELLET EXTRUSION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SCANNING ELECTRON MICROSCOPY; SPHERONIZATION; TABLET FRIABILITY; X RAY DIFFRACTION;

EID: 84866687006     PISSN: 09751483     EISSN: 09751505     Source Type: Journal    
DOI: 10.4103/0975-1483.100020     Document Type: Article

References (21)

1. Murray MD, Haag KM, Black PK, Hall SD, Brater DC. Variable furosemide absorption and poor predictability of response in elderly patient. Pharmacotherapy 1997;17:98-106.
2. Filippis PD, Zingone G, Gibellini M, Rubessa F, Rupena P. Dissolution rates of different drugs from solid dispersions with Eudragit RS. Eur J Pharm Sci 1995;3(5): 265-71.
3. Otsuka M, Onoe M, Matsuda Y. Hygroscopic stability and dissolution properties of spray-dried solid dispersions of furosemide with eudragit. J Pharm Sci 2006;82:32-8.
4. Boles Ponto LL, Schoenwald RD. Furosemide: A pharmacokinetic/ pharmacodynamic review part I. Clin Pharmacokinet 1990;18:381-408.
5. Ozdmir N, Ordu S. Improvement of dissolution properties of furosemide by complexation with β-cyclodextrin. Drug Dev Ind Pharm 1998;24:19-25.
6. Klausner EA, Lavy E, Stepensky D, Cserepes E, Barta M, Friedman M, et al. Furosemide pharmacokinetics and pharmacodynamics following gastro retentive dosage form administration to healthy volunteers. J Clin Pharmacol 2003;43:711-20.
7. Maeda T, Takenaka H, Yamahira Y, Noguchi T. Use of rabbits for GI drug absorption studies: Relationship between dissolution rate and bioavailability of griseofulvin tablets. J Pharm Sci 1979;68:1286-9.
8. Kislalioglu MS, Khan MA, Blount C, Goettsch RW, Bolton S. Physical characterization and dissolution properties of ibuprofen: Eudragits coprecipitates. J Pharm Sci 1991;80:799-804.
9. Mooter GV, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P, et al. Physical stabilization of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci 2000;12:261-9.
10. Moyano JR, Arias MJ, Gines JM, Rabasco AM. Dissolution behaviour of oxazepam in presence of cyclodextrins-evaluation of oxazepam-dimeb binary system. Drug Dev Ind Pharm 1997;23:379-85.
11. Gruenhagen HH. Melt extrusion technology. Pharm Manuf Int 1995; 2:167-70.
12. Erkoboni DF. Extrusion/spheronization. In: Pharmaceutical Extrusion Technology. New York: Marcel Dekker; 2003.
13. Ott AD, Thommes M, Remon JP, Kleinebudde P, Vervaet C. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose. Eur J Pharm Biopharm 2009;71:38-46.
14. Schilling SU, Shah NH, Malick AW, McGinity JW. Properties of melt extruded enteric matrix pellets. Eur J Pharm Biopharm 2010;74:352-61.
15. Gotti R, Furlanetto S, Andrisano V, Cavrini V, Pinzauti S. Design of experiments for capillary electrophoretic enantioresolution of salbutamol using dermatan sulphate. J Chromatogr 2000;875:411-22.
16. Singh G, Pai RS, Devi VK. Response surface methodology and process optimization of sustained release pellets using Taguchi orthogonal array design and central composite design. J Adv Pharm Technol Res 2012;3:30-40.
17. Singh R, Poddar SS, Chivate A. Sintering of wax for controlling release from pellets. AAPS PharmSciTech 2007;8:E175-83.
18. Clarke GM, Newton JM, Short MB. Comparative gastrointestinal transit of pellet systems of varying density. Int J Pharm 1995;114:1-11.
19. Souto C, Rodr?guez A, Parajes S, Pacheco RM. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization. Eur J Pharm Biopharm 2005;61:94-9.
20. Vijayalakshmi P, Devi VK, Narendra C, Srinagesh S. Development of extended zero-order release gliclazide tablets by central composite design. Drug Dev Ind Pharm 2008;34:33-45.
21. Nayak AK, Laha B, Sen KK. Development of hydroxyapatite-ciprofloxacin bone-implants using Quality by design. Acta Pharm 2011;61:25-36.